Drug Trial Radar · NCT00408408
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Last checked: Nov 19, 2026Latest source record: Sep 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,206
Actual
Start
Nov 2006
Primary completion
Mar 2011
Study completion Mar 2018
Sponsor
- Lead sponsor
- NSABP Foundation IncResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Dec 7, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of breast cancer by blocking blood flow to the tumor. Giving chemotherapy and bevacizumab before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving bevacizumab after surgery may kill any tumor cells that remain after surgery. It is not yet known which chemotherapy regimen is more effective with or without bevacizumab in treating breast cancer. PURPOSE: This randomized phase III trial is studying six different chemotherapy regimens to compare how well they work with or without bevacizumab in treating women with stage I, stage II, or stage IIIA breast cancer that can be removed by surgery.
Conditions
- Breast Cancer
Interventions
bevacizumabBiological
15 mg/kg IV
capecitabineDrug
825 mg/m2 orally
cyclophosphamideDrug
600 mg/m2 IV
docetaxelDrug
100 mg/m2 IV
doxorubicin hydrochloride (Adriamycin)Drug
60 mg/m2 IV
gemcitabine hydrochlorideDrug
1000 mg/m2 IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pathologic Complete Response (pCR) of the Primary Tumor in the BreastTime frame: Time of surgery, on average 6 or 13 months
Locations
442 sites in 3 countries. Site status is shown where the registry gives one.
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas
East Bay Radiation Oncology Center
Castro Valley, California
Eden Medical Center
Castro Valley, California
Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California
Kaiser Permanente - Fremont
Fremont, California
Valley Medical Oncology
Fremont, California
Cancer Care Associates
Fresno, California
Kaiser Permanente Medical Center - Hayward
Hayward, California
Scripps Cancer Center - San Diego
La Jolla, California
Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California
Contra Costa Regional Medical Center
Martinez, California
El Camino Hospital Cancer Center
Mountain View, California
Highland General Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Breast Surgeons, Incorporated
Oakland, California
CCOP - Bay Area Tumor Institute
Oakland, California
Larry G Strieff MD Medical Corporation
Oakland, California
Tom K Lee, Incorporated
Oakland, California
Kaiser Permanente Medical Center - Oakland
Oakland, California
St. Joseph Hospital Regional Cancer Center - Orange
Orange, California
Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California
Valley Care Medical Center
Pleasanton, California
Valley Medical Oncology Consultants - Pleasanton
Pleasanton, California
Kaiser Permanente Medical Center - Redwood City
Redwood City, California
Kaiser Permanente Medical Center - Richmond
Richmond, California
Kaiser Permanente Medical Center - Roseville
Roseville, California
South Sacramento Kaiser-Permanente Medical Center
Sacramento, California
Kaiser Permanente Medical Center - Sacramento
Sacramento, California
Salinas Valley Memorial Hospital
Salinas, California
Kaiser Permanente Medical Office -Vandever Medical Office
San Diego, California
Kaiser Permanente Medical Center - San Francisco Geary Campus
San Francisco, California
Kaiser Permanente Medical Center - Santa Teresa
San Jose, California
Doctors Medical Center - San Pablo Campus
San Pablo, California
Kaiser Foundation Hospital - San Rafael
San Rafael, California
Kaiser Permanente Medical Center - Santa Clara Kiely Campus
Santa Clara, California
Kaiser Permanente Medical Center - Santa Rosa
Santa Rosa, California
Kaiser Permanente Medical Center - South San Francisco
South San Francisco, California
Kaiser Permanente Medical Facility - Stockton
Stockton, California
Kaiser Permanente Medical Center - Vallejo
Vallejo, California
Kaiser Permanente Medical Center - Walnut Creek
Walnut Creek, California
Showing 40 of 442 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.